Our industry partners rank legislative and regulatory knowledge as one of the most commonly overlooked aspects of our biotech training. Do you have an interest in learning about the cutting edge of biologics and biosimilar alternatives to small molecule drugs? Are intrigued by the legislative process driving pharmaceutical and biotechnology innovation?
As costs climb and blockbuster drugs come off patent, the pharmaceutical industry has become a bit of a lightning rod for controversy.
We invite you to join us with our partners at SCBIO for Discovering Cures Day where experts from Novartis and Amgen will be on hand to discuss opportunities for cost control through production generic biosimilars.
Find out more about biosimilars and the blockbuster drugs that might be produced as generics as their patents expire: https://www.thebalance.com/top-biologic-drugs-2663233
Registration and professional attire are required for this event. Please sign-up and indicate if you would like to assist in setting up for the event below.